|
|
| News Archive |
Launch of DIRECT - An Innovative Medicines Initiative Project for Personalized Medicine in Diabetes
Thursday, February 23, 2012
Academia and the pharmaceutical industry working together in the fight against diabetes.
Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of Debio 0932
Tuesday, February 21, 2012
Company expects to initiate a combination Phase I/II study in NSCLC patients in the second quarter of 2012.
NIH Common Fund Researchers Uncover Structure of Important Target for Drug Design
Tuesday, February 21, 2012
Researchers have uncovered a potent class of small molecules that selectively turn on the S1P1 receptor.
PRECOS to Unveil New Service Portfolio at Cancer Targets & Therapeutics and AACR 2012
Tuesday, February 21, 2012
2012 conference examines new and emerging targets and therapeutics in the area of cancer research.
PRECOS Appoints Dr Martin Page as Scientific Consultant
Tuesday, February 21, 2012
Appointment reinforces the ambition of PRECOS to contribute to the growing cancer therapy market.
Provepharm Announces Impressive Trading and Financial Results for 2011
Friday, February 17, 2012
The company also closed a EUR 2.7 million funding round in December.
Evotec and IR Pharma Establish Drug Discovery Alliance
Thursday, February 16, 2012
Companies have entered into an exclusive strategic alliance to provide integrated drug discovery solutions to Pharmaceutical and Biotech companies in the field of Respiratory Diseases.
Drug Halts Organ Damage in Inflammatory Genetic Disorder
Monday, February 13, 2012
NIH study shows benefits of long-term Kineret therapy in people with NOMID.
Nuvo Research Announces Management Change
Monday, February 13, 2012
Stephen L. Lemieux to become Vice President and Chief Financial Officer of Nuvo Research.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 3457 |
|
|
